Removal of blood amyloid-β with hemodialysis reduced brain amyloid-β, confirmed by brain imaging: A case report

Nobuya Kitaguchi, Takashi Kato, Shinji Matsunaga, Kyoko Hirano, Kaori Iwata, Kazunori Kawaguchi, Kiyoshi Fujita, Hajime Takechi, Midori Hasegawa, Yukio Yuzawa, Kengo Ito

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The accumulation of amyloid-β protein (Aβ) in the brain signifies a major pathological change of Alzheimer’s disease (AD). Extracorporeal blood Aβ removal system (E-BARS) has been under development as a tool for enhancing the clearance of Aβ from the brain. Previously, we revealed that dialyzers remove blood Aβs effectively, evoking substantial Aβ influx into the blood during hemodialysis sessions as one form of blood Aβ removal by E-BARS, and that postmortem brains of hemodialysis patients exhibited lower Aβ accumulation. Here, we present a case report of a 77-year-old male patient with end-stage renal failure whose Aβ accumulation in the brain declined by initiating and continuing hemodialysis for 6 months. This report suggests that blood Aβ removal by E-BARS could be an effective therapeutic method for AD.

Original languageEnglish
Pages (from-to)2931-2937
Number of pages7
JournalNeuropsychiatric Disease and Treatment
Volume14
DOIs
Publication statusPublished - 01-01-2018

Fingerprint

Amyloid
Neuroimaging
Renal Dialysis
Brain
Alzheimer Disease
Artificial Kidneys
Serum Amyloid A Protein
Chronic Kidney Failure

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Kitaguchi, Nobuya ; Kato, Takashi ; Matsunaga, Shinji ; Hirano, Kyoko ; Iwata, Kaori ; Kawaguchi, Kazunori ; Fujita, Kiyoshi ; Takechi, Hajime ; Hasegawa, Midori ; Yuzawa, Yukio ; Ito, Kengo. / Removal of blood amyloid-β with hemodialysis reduced brain amyloid-β, confirmed by brain imaging : A case report. In: Neuropsychiatric Disease and Treatment. 2018 ; Vol. 14. pp. 2931-2937.
@article{7e77a9ad7bcc4b7b86e6a706af1466c1,
title = "Removal of blood amyloid-β with hemodialysis reduced brain amyloid-β, confirmed by brain imaging: A case report",
abstract = "The accumulation of amyloid-β protein (Aβ) in the brain signifies a major pathological change of Alzheimer’s disease (AD). Extracorporeal blood Aβ removal system (E-BARS) has been under development as a tool for enhancing the clearance of Aβ from the brain. Previously, we revealed that dialyzers remove blood Aβs effectively, evoking substantial Aβ influx into the blood during hemodialysis sessions as one form of blood Aβ removal by E-BARS, and that postmortem brains of hemodialysis patients exhibited lower Aβ accumulation. Here, we present a case report of a 77-year-old male patient with end-stage renal failure whose Aβ accumulation in the brain declined by initiating and continuing hemodialysis for 6 months. This report suggests that blood Aβ removal by E-BARS could be an effective therapeutic method for AD.",
author = "Nobuya Kitaguchi and Takashi Kato and Shinji Matsunaga and Kyoko Hirano and Kaori Iwata and Kazunori Kawaguchi and Kiyoshi Fujita and Hajime Takechi and Midori Hasegawa and Yukio Yuzawa and Kengo Ito",
year = "2018",
month = "1",
day = "1",
doi = "10.2147/NDT.S186118",
language = "English",
volume = "14",
pages = "2931--2937",
journal = "Neuropsychiatric Disease and Treatment",
issn = "1176-6328",
publisher = "Dove Medical Press Ltd.",

}

Removal of blood amyloid-β with hemodialysis reduced brain amyloid-β, confirmed by brain imaging : A case report. / Kitaguchi, Nobuya; Kato, Takashi; Matsunaga, Shinji; Hirano, Kyoko; Iwata, Kaori; Kawaguchi, Kazunori; Fujita, Kiyoshi; Takechi, Hajime; Hasegawa, Midori; Yuzawa, Yukio; Ito, Kengo.

In: Neuropsychiatric Disease and Treatment, Vol. 14, 01.01.2018, p. 2931-2937.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Removal of blood amyloid-β with hemodialysis reduced brain amyloid-β, confirmed by brain imaging

T2 - A case report

AU - Kitaguchi, Nobuya

AU - Kato, Takashi

AU - Matsunaga, Shinji

AU - Hirano, Kyoko

AU - Iwata, Kaori

AU - Kawaguchi, Kazunori

AU - Fujita, Kiyoshi

AU - Takechi, Hajime

AU - Hasegawa, Midori

AU - Yuzawa, Yukio

AU - Ito, Kengo

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The accumulation of amyloid-β protein (Aβ) in the brain signifies a major pathological change of Alzheimer’s disease (AD). Extracorporeal blood Aβ removal system (E-BARS) has been under development as a tool for enhancing the clearance of Aβ from the brain. Previously, we revealed that dialyzers remove blood Aβs effectively, evoking substantial Aβ influx into the blood during hemodialysis sessions as one form of blood Aβ removal by E-BARS, and that postmortem brains of hemodialysis patients exhibited lower Aβ accumulation. Here, we present a case report of a 77-year-old male patient with end-stage renal failure whose Aβ accumulation in the brain declined by initiating and continuing hemodialysis for 6 months. This report suggests that blood Aβ removal by E-BARS could be an effective therapeutic method for AD.

AB - The accumulation of amyloid-β protein (Aβ) in the brain signifies a major pathological change of Alzheimer’s disease (AD). Extracorporeal blood Aβ removal system (E-BARS) has been under development as a tool for enhancing the clearance of Aβ from the brain. Previously, we revealed that dialyzers remove blood Aβs effectively, evoking substantial Aβ influx into the blood during hemodialysis sessions as one form of blood Aβ removal by E-BARS, and that postmortem brains of hemodialysis patients exhibited lower Aβ accumulation. Here, we present a case report of a 77-year-old male patient with end-stage renal failure whose Aβ accumulation in the brain declined by initiating and continuing hemodialysis for 6 months. This report suggests that blood Aβ removal by E-BARS could be an effective therapeutic method for AD.

UR - http://www.scopus.com/inward/record.url?scp=85057568310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057568310&partnerID=8YFLogxK

U2 - 10.2147/NDT.S186118

DO - 10.2147/NDT.S186118

M3 - Article

AN - SCOPUS:85057568310

VL - 14

SP - 2931

EP - 2937

JO - Neuropsychiatric Disease and Treatment

JF - Neuropsychiatric Disease and Treatment

SN - 1176-6328

ER -